Enhanced expression of cytokines/chemokines in cerebrospinal fluids in mumps meningitis in children

Pediatrics International

Volumn 53, Issue 2, 2011, Pages 143-146

  Asano, Takeshi ^a   Ichiki, Kunihiko ^a   Koizumi, Shinya ^a   Kaizu, Kiyohiko ^a   Hatori, Takayuki ^a   Fujino, Osamu ^a   Mashiko, Kunihiro ^a   Sakamoto, Yuichiro ^a   Miyasho, Taku ^b   Fukunaga, Yoshitaka ^a  

^a NIPPON MEDICAL SCHOOL CHIBA HOKUSOH HOSPITAL   (Japan)

^b RAKUNO GAKUEN UNIVERSITY   (Japan)

Author keywords

chemokine; cytokine; meningitis; mumps

Indexed keywords

CHEMOKINE; CYTOKINE; GAMMA INTERFERON; GRANULOCYTE COLONY STIMULATING FACTOR RECEPTOR; GRANULOCYTE MACROPHAGE COLONY STIMULATING FACTOR; INTERLEUKIN 10; INTERLEUKIN 12; INTERLEUKIN 13; INTERLEUKIN 17; INTERLEUKIN 1BETA; INTERLEUKIN 2; INTERLEUKIN 4; INTERLEUKIN 5; INTERLEUKIN 6; INTERLEUKIN 7; INTERLEUKIN 8; MACROPHAGE INFLAMMATORY PROTEIN 1BETA; MONOCYTE CHEMOTACTIC PROTEIN 1; TUMOR NECROSIS FACTOR ALPHA;

ARTICLE; ASEPTIC MENINGITIS; CEREBROSPINAL FLUID; CHILD; CLINICAL ARTICLE; CONTROLLED STUDY; FEMALE; FEVER; HUMAN; MALE; MENINGITIS; MUMPS; PRESCHOOL CHILD; PRIORITY JOURNAL; PROTEIN BLOOD LEVEL; PROTEIN EXPRESSION; SCHOOL CHILD; VIRUS INFECTION; VIRUS MENINGITIS;

CHEMOKINE CCL2; CHEMOKINE CCL4; CHEMOKINES; CHILD; CYTOKINES; FEMALE; HUMANS; INTERFERON-GAMMA; INTERLEUKINS; MALE; MENINGITIS, ASEPTIC; MUMPS;

EID: 79955055689     PISSN: 13288067     EISSN: 1442200X     Source Type: Journal    
DOI: 10.1111/j.1442-200X.2010.03215.x     Document Type: Article

References (9)

1. Rotbart HA,. Viral meningitis. Semin. Neurol. 2000; 20: 277-92.
2. Ichiyama T, Maeba S, Suenaga N, Saito K, Matsubara T, Furukawa S,. Analysis of cytokine levels in cerebrospinal fluid in mumps meningitis: Comparison with echo virus type 30 meningitis. Cytokine 2005; 30: 243-7. (Pubitemid 40775842)
3. Martin R, Vallbracht A, Kreth HW,. Interferon-Iα secretion by in vivo activated cytotoxic T lymphocytes from the blood and cerebrospinal fluid during mumps meningitis. J. Neuroimmunol. 1991; 33: 191-8.
4. Beran O, Lawrence DA, Andersen N, et al,. Sequential analysis of biomarkers in cerebrospinal fluid and serum during invasive meningococcal disease. Eur. J. Clin. Microbiol. Infect. Dis. 2009; 28: 793-9.
5. Dhiman N, Ovsyannikova IG, Vierkant RA, Pankratz VS, Jacobson RM, Poland GA,. Association between cytokine/cytokine receptor single nucleotide polymorphism and humoral immunity to measles, mumps and rubella in a Somali population. Tissue Antigen 2008; 72: 211-20.
6. Jokinen S, Osterlund P,. Julkunen I and Davidkin I. Cellular immunity to mumps virus in young adults 21 years after Measles-Mumps-Rubella vaccination. J. Infect. Dis. 2007; 196: 861-7. (Pubitemid 47378935)
7. Orange JS, Wang B, Terhorst C, Biron CA,. Requirement for natural killer cell-produced interferon gamma in defense against murine cytomegalovirus infection and enhancement of this defense pathway by interleukin 12 administration. J. Exp. Med. 1995; 182: 1045-56.
8. Trinchieri G,. Interleukin-12: A proinflammatory cytokine with immunoregulatory functions that bridge innate resistance and antigen-specific adaptive immunity. Annu. Rev. Immuno. 1995; 13: 251-76.
9. Langford D, Masliah E,. Role of trophic factors on neuroimmunity in neurodegenerative infectious diseases. J. NeuroVirol. 2002; 8: 625-38. (Pubitemid 36104725)